The Visian® ICL is an artificial lens made of a bio-compatible material that is surgically implanted inside the eye behind the iris and in front of the natural lens to correct myopia and astigmatism in a permanent fashion. It cannot be seen by the naked eye so others will not know it is there. It is approved by the US FDA and over 500,000 have been implanted worldwide with satisfaction rates of over 95 %.
The Visian® ICL works by bending light rays to allow them to focus on the retina accurately to provide for clear distance vision. It is able to correct myopia of up to -18 D and astigmatism of -6 D.
The Visian® ICL is used in patients between 21 – 45 years of age, who do not have cataracts and are generally not suitable for corneal laser refractive surgery, usually because their corneas are too thin.
Surgery is usually performed under local anaesthesia with sedation and takes about 30 minutes. It is important not to rub your eyes for a week after surgery and topical medicated eye drops are prescribed for a few weeks after surgery. In general, visual clarity is achieved in the first few days after surgery.
Results after surgery may vary and the Visian® ICL may not be suitable for everyone. For example, if there is insufficient space in the front of the eye for safe insertion or if the cornea is not healthy enough. Like any surgical treatment, ICL surgery is associated risks such as: infection, retinal detachment, increase in intra-ocular pressure, cataract formation and the need for a second surgery. It is important to consult an eye surgeon to better understand the risks and benefits of ICL surgery and to determine if you are suitable for the procedure or if there are any other vision correction options.